News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Pharmaceuticals Board of Directors


9/20/2011 10:43:44 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the appointment of Marc Tessier-Lavigne, Ph.D., to its board of directors. Dr. Tessier-Lavigne is president of The Rockefeller University and formerly served as executive vice president for research and chief scientific officer at Genentech, where he directed 1,400 people in disease research and drug discovery in cancer, immune disorders, infectious diseases and neurodegenerative diseases.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES